Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report. (4th September 2019)

• Record Type: Journal Article
• Authors: Howard-Anderson, Jessica; Pouch, Stephanie M; Sexton, Mary Elizabeth; Mehta, Aneesh K; Smith, Andrew L; Lyon, George M; Friedman-Moraco, Rachel
• Is Part Of: Open forum infectious diseases. Volume 6:Number 9(2019)
• Publication Date: 2019-09-04
• Subjects: dalbavancin -- left ventricular assist devices -- Staphylococcus aureus; Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofz235
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: Left ventricular assist device infections (LVADIs) are common but challenging to treat, often requiring prolonged courses of intravenous antibiotics. Dalbavancin could have a role in treating patients with chronic LVADIs given its less frequent dosing requirements. Here, we illustrate a case in which dalbavancin was used as suppressive therapy for an LVADI for greater than 7 months.